# Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-bcma-gprc5d-bispecific-car-t-cells-in-patients-with-relapsed-or-refractory/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dian Zhou,Qian Sun,Jieyun Xia,Weiying Gu,Jun Qian,Wanchuan Zhuang,Zhiling Yan,Hai Cheng,Wei Chen,Feng Zhu,Kunming Qi,Depeng Li,Wei Sang,Lili Zhu,Sha Ma,Hujun Li,Huan-Xin Zhang,Tingting Qiu,Dongmei Yan,Yanlei Zhang,Shuixiu Peng,Alex H. Chang,Kailin Xu,Zhenyu Li |
| Citations | 53 |
| DOI | 10.1016/s2352-3026(24)00176-5 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4400901230 |
| PMID | 39059405 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Jieyun Xia](https://scholariq.org/researchers/jieyun-xia/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.